EP2582383A4 - Peptidzusammensetzung zur arthritisbehandlung durch regulation angeborener defizite - Google Patents

Peptidzusammensetzung zur arthritisbehandlung durch regulation angeborener defizite

Info

Publication number
EP2582383A4
EP2582383A4 EP11794988.3A EP11794988A EP2582383A4 EP 2582383 A4 EP2582383 A4 EP 2582383A4 EP 11794988 A EP11794988 A EP 11794988A EP 2582383 A4 EP2582383 A4 EP 2582383A4
Authority
EP
European Patent Office
Prior art keywords
arthritis
peptide
initiated
treatment
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11794988.3A
Other languages
English (en)
French (fr)
Other versions
EP2582383A2 (de
Inventor
Neeloffer Mookherjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Original Assignee
University of Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba filed Critical University of Manitoba
Publication of EP2582383A2 publication Critical patent/EP2582383A2/de
Publication of EP2582383A4 publication Critical patent/EP2582383A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP11794988.3A 2010-06-15 2011-06-14 Peptidzusammensetzung zur arthritisbehandlung durch regulation angeborener defizite Withdrawn EP2582383A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35508810P 2010-06-15 2010-06-15
PCT/CA2011/000703 WO2011156903A2 (en) 2010-06-15 2011-06-14 Innate defence regulatory peptide compositions for treatment of arthritis

Publications (2)

Publication Number Publication Date
EP2582383A2 EP2582383A2 (de) 2013-04-24
EP2582383A4 true EP2582383A4 (de) 2013-12-04

Family

ID=45348591

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11794988.3A Withdrawn EP2582383A4 (de) 2010-06-15 2011-06-14 Peptidzusammensetzung zur arthritisbehandlung durch regulation angeborener defizite

Country Status (4)

Country Link
US (1) US20130316963A1 (de)
EP (1) EP2582383A4 (de)
CA (1) CA2802912A1 (de)
WO (1) WO2011156903A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160289287A1 (en) * 2013-08-27 2016-10-06 The University Of British Columbia Small cationic anti-biofilm and idr peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660668C (en) * 2006-08-21 2016-06-28 The University Of British Columbia Small cationic antimicrobial peptides
WO2010026489A1 (en) * 2008-09-05 2010-03-11 The University Of British Columbia Innate immunity modulators

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EMILY TURNER-BRANNEN ET AL: "Modulation of interleukin-1Î-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, vol. 13, no. 4, 11 August 2011 (2011-08-11), pages R129, XP021109768, ISSN: 1478-6354, DOI: 10.1186/AR3440 *

Also Published As

Publication number Publication date
US20130316963A1 (en) 2013-11-28
WO2011156903A2 (en) 2011-12-22
WO2011156903A3 (en) 2012-02-02
EP2582383A2 (de) 2013-04-24
CA2802912A1 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
MX2013013913A (es) Polipeptidos.
MX383887B (es) Composiciones farmacéuticas y uso de las mismas para la prevención y el tratamiento de cardiomiopatía asociada a la ataxia de friedreich.
AU2015317711B2 (en) Compositions comprising recombinant Bacillus cells and another biological control agent
UA118167C2 (uk) Пептид та його застосування
BR112015026307A2 (pt) heterociclo bicíclicos como inibidores de fgfr
EA201390225A1 (ru) НЕМАТОЦИДНАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ Bacillus subtilis И Bacillus licheniformis
EA201491496A1 (ru) Ингибиторы c-концевого домена hsp90
AR083162A1 (es) Uso de ingredientes activos para controlar nematodos en cultivos resistentes a nematodos
UA117218C2 (uk) Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
MX374477B (es) Composicion y productos que comprenden celulas senescentes para su uso en la regeneracion de tejidos
MX373549B (es) Derivado de pirazol amida.
EP4414376A3 (de) Neues depsipeptid und verwendungen davon
UA117096C2 (uk) Поліпептид, що зв'язується з c5 комплементу людини
MD20160007A2 (ro) Inhibitori ai RORC2 şi metode de utilizare a acestora
MX2018000590A (es) Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79).
BR112014011254A2 (pt) 2-tiopirimidinonas
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
GB201118201D0 (en) Novel peptides
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
BR112017019605A2 (pt) compostos heterocíclicos úteis como inibidores de tnf
MX2015016492A (es) Peptidos de y conotoxina, composicion farmaceutica y usos de los mismos.
BR112017019731A2 (pt) compostos heterocíclicos tricíclicos úteis como inibidores de tnf
BR112015001096A2 (pt) derivados de di e tri-heteroaril como inibidores de agregação de proteína
EA201792346A1 (ru) ПРИМЕНЕНИЕ sGC СТИМУЛЯТОРОВ, sGC АКТИВАТОРОВ, ОТДЕЛЬНО И В КОМБИНАЦИЯХ С PDE5 ИНГИБИТОРАМИ, ДЛЯ ЛЕЧЕНИЯ ПАЛЬЦЕВИДНЫХ ЯЗВ (DU), СОПУТСТВУЮЩИХ СИСТЕМНОМУ СКЛЕРОЗУ (SSc)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130111

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131031

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/10 20060101AFI20131025BHEP

Ipc: A61P 29/00 20060101ALI20131025BHEP

Ipc: A61P 19/02 20060101ALI20131025BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160105